Courtney Bradley
Family · Connersville, INNPI 1083241012
Payments from drug & device makers
Across 185 payments — averaging $16.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$973
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$395
- Otsuka America Pharmaceutical, Inc.$304
- Gilead$214
- Vanda Pharmaceuticals Inc.$198
- Indivior Inc.$168
- plus $856 from 17 others
What the payments were for
- Food & beverage$3,02597%
- Education$833%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 67 | $973 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 19 | $395 |
| Otsuka America Pharmaceutical, Inc. | 16 | $304 |
| Gilead | 13 | $214 |
| Vanda Pharmaceuticals Inc. | 10 | $198 |
| Indivior Inc. | 10 | $168 |
| Lundbeck LLC | 9 | $151 |
| Axsome Therapeutics, Inc. | 6 | $109 |
| Hologic Sales And Service, LLC | 4 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $83 |
| Novo Nordisk | 5 | $73 |
| GSK | 4 | $67 |
| Lilly USA, LLC | 3 | $53 |
| Catalyst Orthoscience | 1 | $45 |
| Supernus Pharmaceuticals, Inc. | 2 | $35 |
| Bayer | 2 | $29 |
| Braeburn Inc. | 2 | $29 |
| Alkermes, Inc. | 1 | $17 |
| Tris Pharma Inc | 1 | $15 |
| Orexo US, Inc. | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Corium, LLC | 1 | $13 |
| AstraZeneca | 1 | $13 |
How this compares
$3,108 in reported general payments places this provider in the 85th percentile of 4,392 family providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 67 | $43,986 |
| RybelsusSemaglutide | 12 | $23,935 |
| LinzessLinaclotide | 12 | $11,725 |
| OzempicSemaglutide | 11 | $10,562 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 17 | $9,411 |
| TrintellixVortioxetine Hydrobromide | 14 | $6,596 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 13 | $6,305 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 155 | $4,418 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 26 | $3,556 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 25 | $2,819 |
| Trazodone Hcl | 58 | $1,410 |
| Ventolin HfaAlbuterol Sulfate | 14 | $1,368 |
| Buprenorphine Hcl | 13 | $1,152 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $1,112 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 51 | $1,097 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $67 | $43,98667 claims |
| Novo NordiskRybelsus, Ozempic | $73 | $34,49723 claims |
| AbbVieLinzess | $973 | $11,72512 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $83 | $6,59614 claims |
| Indivior Inc.Suboxone | $168 | $6,30513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,392 family providers in Indiana.
Other family in Connersville
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
- Elizabeth JohnsonEvansville$108K
- Beverly MaugerFt Wayne$94K
- Nancy ArndtPortage$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.